Skip to main content
letter
. 2021 Oct-Dec;33(4):640–643. doi: 10.5935/0103-507X.20210090

Table 3.

Clinical outcomes of all patients receiving high-flow nasal cannula therapy those with and without epistaxis

Variable Total n = 70 Epistaxis n = 7 No epistaxis n = 63 p value
Need of mechanical ventilation after HFNC therapy 33 (47.1) 3 (42.9) 30 (47.6) 1
ICU mortality 30 (42.9) 3 (42.9) 27 (42.9) 1
ICU length-of-stay (days) 12 [7 - 22] 21 [6 - 22] 12 [7 - 20.5] 0.92
In-hospital mortality 40 (57.1) 4 (57.1) 36 (57.1) 1
In-hospital length-of-stay (days) 28.5 [16 - 48.5] 28 [15 - 33] 29 [16.5 - 49.5] 0.41

HFNC - high-flow nasal cannula; ICU - intensive care unit. Results expressed as n (%) or median [interquartile range].